The State Council held an executive meeting: medicine should uphold the characteristics

The executive meeting of the State Council will strengthen the "original research drugs, first imitation drugs, Traditional Chinese medicine, new preparations, high-end medical devices" and other important positions, require the international advanced level, improve the safety evaluation and product traceability system, promote the intelligent and green transformation of the pharmaceutical production process, support the merger and reorganization of pharmaceutical enterprises, cultivate leading enterprises, have grasped the core of the problem. Domestic pharmaceutical enterprises can only improve the quality of products and services, in order to better meet the nation's ever-increasing demand for medical and health services.
chinese medicine represents the essence of traditional Chinese culture, but in the total plate of China's pharmaceutical industry, the proportion of Chinese medicine plate is only more than 20%, the development potential is huge.
, especially with the progress of science and technology and the improvement of material living standards, people need more and more health, health and old-age services. The concept of "cure the disease", conditioning, prevention and treatment is obviously necessary to rely on Chinese medicine to complete. Therefore, it is an important hand to improve the overall competitiveness of China's pharmaceutical industry to support and accelerate the development of Chinese medicine industry through policy guidance. The policy content of this introduction is also targeted at precision: for example, the core issue of the current development of Chinese medicine is to train high-level Chinese medicine talents, the key is to protect the resources and improve the quality of Chinese medicine, focus on expanding the network of Chinese medicine services. As long as China's Chinese medicine industry in maintaining characteristics at the same time, with a more open mind, will certainly usher in greater development.
domestic pharmaceutical enterprises to really become stronger and bigger, we must take the road of research and development, innovation. Of course, innovation is more than one path, technological innovation is important, business model innovation is also very important. Especially at the moment of rapid development of Internet technology, pharmaceutical companies must not just build cars behind closed doors, we must firmly grasp the latest trends in technology development and market demand. For example, some enterprises around the large health industry, actively layout based on the Internet, Internet of Things, big data, cloud computing, intelligent production, intelligent distribution and other technologies first new business model, seeking to launch a variety of health consumer goods will be fully based on personal data and personalized needs on the basis of flexible customization, etc. , are useful exploration. In short, under the background of the country's clear support for the development of the Chinese medicine industry, the domestic Chinese medicine industry will release great potential for development as long as it adheres to research and development, innovation and grasps market trends from the perspective of implementing supply-side reform. (Global Network)